The evolution of clinical research has been dependent on the conversion of Healthcare Organizations (HCOs) to clinical research sites, along with the conversion of Healthcare Providers (HCPs) to Princ…
Pharma has changed a lot in recent years. The rules and regulations surrounding develo…
Janssen, a brand name that for six decades has been emblazoned on Johnson & Johnson’s pharmaceutical laboratories and prescription drugs, will be phased out as part of a corporate rebranding in th…
The decision is the first verdict based on data from a wider immunotherapy ‘basket’ study
MSD has revealed that the National Institute for Health and Care Excellence (NICE) has recommended the use of …
It was only last spring that Biogen started a round of layoffs that eventually shrank the company’s head count by nearly 900 people last year. Now, a fresh round of job cuts targeting 1,000 positions …
Aquablation is a robotic method that uses a high-pressure saline solution to remove tissue
The Norfolk and Norwich University Hospitals (NNUH) Urology team have become the first in the East of England…
To book via Eventbrite and see the full agenda visit our Website
If you have any questions please email office@icr-global.org
Reef Group and UBS Asset Management have gained approval to develop one of Europe’s largest life sciences campuses in Stevenage, UK.
The family of Henrietta Lacks is suing rare disease drug developer Ultragenyx over its use of technology built from her cells, which were taken without her knowledge or consent in 1951 and immortalize…
Oxford Cannabinoid Technologies Holdings (OCTP) – the company developing prescription cannabinoid medicines – is expanding its research and development plans into oncology. The decision comes after it…
For those of us who use sophisticated digital tools every day, it’s easy to assume that technology always makes life easier. It doesn’t.
TauRx Pharmaceuticals – a company focused on Alzheimer’s disease (AD) research – has announced results from its pivotal phase 3 LUCIDITY trial.
The study measured the effect of hydromethylthionine mes…
Digital technologies designed to support clinical trial management have evolved greatly over the years, spurred by increasing complexity in study design, emerging technologies in specific therapeutic …
On Thursday, the Food and Drug Administration awarded a full approval to the Alzheimer’s disease treatment Leqembi, a decision expected to significantly increase use of the therapy and, potentially, o…
The surge of wearable sensors is transforming the clinical trial experience for patients, sponsors, and research sites. Sensors can be worn by the patient 24/7 to capture physiology continuously, prov…
The proliferation of AI/ChatGPT resources during the initial months of 2023 has raised several questions across the pharma industry around it…
In this episode of "The Top Line," we talk with Fierce’s Andrea Park and Gabrielle Masson about the latest from the American Diabetes Association's annual conference. We also cover a statement about t…
BioMarin Pharmaceutical, having secured a long-awaited approval from the Food and Drug Administration, says its focus has now turned to launching its new hemophilia gene therapy in the U.S. market.
In the battle for superiority in the field of next-gen diabetes and obesity treatments, Novo Nordisk holds the lead as the developer of the metabolism-regulating treatment semaglutide.
Last year, the top winners at the prestigious Pharma Lions event at Cannes were not in fact pharma companies, and in 2023 that trend continues as a digital face-tracking app, a breast cancer inequalit…